Evidence supporting the use of: Glyceryl monolaurate
For the health condition: Impetigo

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Glyceryl Monolaurate for Impetigo: Scientific Evidence

Glyceryl monolaurate (GML) is a monoglyceride derived from lauric acid, known for its antimicrobial properties. Recent laboratory studies have demonstrated that GML exhibits significant in vitro activity against Staphylococcus aureus and Streptococcus pyogenes, the primary pathogens responsible for impetigo. Specifically, research published in Antimicrobial Agents and Chemotherapy (Schlievert et al., 2019) has shown that GML can disrupt bacterial cell membranes and inhibit toxin production, suggesting a potential therapeutic benefit for skin infections.

However, clinical evidence supporting the use of GML for treating impetigo in humans remains limited. Most of the available data are derived from in vitro experiments and animal models, rather than randomized controlled trials in human subjects with impetigo. While some topical formulations containing GML have been investigated for their ability to reduce skin colonization by pathogenic bacteria, robust clinical trials directly assessing efficacy in impetigo are lacking.

In summary, there is preliminary scientific rationale for considering glyceryl monolaurate as an adjunct or alternative for impetigo management due to its demonstrated antimicrobial activity. Nonetheless, the clinical evidence remains insufficient, and more research is needed before GML can be recommended as a standard treatment for impetigo.

More about Glyceryl monolaurate
More about Impetigo

Products containing Glyceryl monolaurate

We currently have no products on Vitabase that contain this ingredient.